Gabapentin Capsule
Product Images NDC 65862-198

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 65862-198). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Gabapentin Fig1)

An illustration showing the formula for calculating Creatinine Clearance (CLCr) based on patient age, weight, serum creatinine, and a correction factor for female patients.*

FDA Label Image

Gabapentin Fig10

Packaging label for Gabapentin Capsules, USP 300 mg, a capsule dosage form by Aurobindo Pharma Limited. The label indicates the product comes in a package of 10 unit-dose capsules (1 x 10). It includes storage instructions, a barcode, and distributor information for Aurobindo Pharma USA, Inc., with manufacturing in India.*

FDA Label Image

Gabapentin Fig11

Packaging label for Gabapentin Capsules, USP 400 mg presented by Aurobindo Pharma Limited. The label indicates the capsules are unit-dose with a count of 10 (1 x 10). It includes storage instructions, a barcode, and distributor information listed as Aurobindo Pharma USA, Inc., East Windsor, NJ. The label also notes the product is Rx only and advises pharmacists to dispense the Medication Guide separately.*

FDA Label Image

Figure 1 (Gabapentin Fig2)

A line graph depicting mean pain scores over an 8-week period for Gabapentin (3600 mg/day) versus placebo. The x-axis shows weeks from baseline to week 8, separated into a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 9. Gabapentin shows a downward trend in pain score over time compared to the placebo group.*

FDA Label Image

Figure 2 (Gabapentin Fig3)

A line graph showing mean pain scores over 7 weeks, comparing placebo with gabapentin at 1800 mg/day and 2400 mg/day. The x-axis represents weeks including baseline, and the y-axis shows mean pain scores from 0 to 10. The graph distinguishes a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 3 (Gabapentin Fig4)

A bar graph titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares the percentage of responders between placebo (PBO) and gabapentin (GBP) doses in two studies. Study 1 shows 12% for placebo and 29% for GBP 3600 mg. Study 2 shows 14% for placebo and 32% and 34% for GBP 1800 mg and 2400 mg doses, respectively, with statistical significance indicated for GBP doses.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Gabapentin Fig5)

A scatter plot comparing percentage difference against daily dose (mg) for Gabapentin capsules at doses 600, 900, 1200, and 1800 mg. Data points are grouped by three studies labeled Study a, Study b, and Study c, each represented with different shaded squares. The plot shows variation in percentage difference across daily doses and studies.*

FDA Label Image

Package Label-principal Display Panel (100 mg (100 Capsules Bottle))

Label for Gabapentin Capsules, USP 100 mg by Aurobindo Pharma Limited. The label shows the NDC 65862-198-01 and states each capsule contains 100 mg of gabapentin. The package contains 100 capsules. It includes storage instructions, a barcode, and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (300 mg (100 Capsules Bottle))

Label for Gabapentin Capsules, USP 300 mg, a drug for further processing by Aurobindo Pharma USA, Inc. The label states the dosage form as capsules, with a total count of 100 capsules. It includes storage instructions and a medication guide dispensing note, along with manufacturing information indicating the product is made in India by Aurobindo Pharma Limited.*

FDA Label Image

Package Label-principal Display Panel (400 mg (100 Capsules Bottle))

Label for Gabapentin Capsules USP, 400 mg, distributed by Aurobindo Pharma USA, Inc. This label indicates the product contains 400 mg gabapentin per capsule and is available in a package of 100 capsules. It provides storage instructions, prescribing information reference, and a barcode with NDC 65862-200-01. The product is made in India by Aurobindo Pharma Limited as a drug for further processing.*

FDA Label Image

Gabapentin Fig9

Packaging label for Gabapentin Capsules, USP 100 mg. The label indicates the product contains 10 unit-dose capsules per package. It is distributed by Aurobindo Pharma USA, Inc., and states storage instructions and dispensing information. The label includes the NDC 65862-198-10 and highlights the active ingredient strength prominently in green.*

FDA Label Image

Chemical Structure (Gabapentin Str)

Chemical structure of gabapentin, showing a cyclohexane ring bonded to an amino group (CH2NH2) and a carboxymethyl group (CH2CO2H).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.